Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Romualdi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|March 15, 2006
Role of opioid antagonists in the treatment of women with glucoregulation abnormalitiesM Guido, D Romualdi, A Lanzone
Journal of Endocrinological Investigation|April 1, 2004
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: a case reportM Guido, D Romualdi, C Belosi, et al.
Journal of Endocrinological Investigation|October 10, 2013
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized studyD Romualdi, S De Cicco, M Busacca, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2011
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndromeD Romualdi, S De Cicco, V Tagliaferri, et al.
Human Reproduction (Oxford, England)|May 30, 2003
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndromeD Romualdi, M Guido, M Ciampelli, et al.
Human Reproduction (Oxford, England)|March 5, 2004
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndromeM Guido, D Romualdi, R Suriano, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot studyM Guido, D Romualdi, M Giuliani, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndromeM Ciampelli, G Muzj, F Leoni, et al.
Human Reproduction (Oxford, England)|October 21, 2006
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?C Belosi, L Selvaggi, R Apa, et al.
Journal of Endocrinological Investigation|March 9, 2019
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort studyD Romualdi, V Versace, V Tagliaferri, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|March 15, 2006
Role of opioid antagonists in the treatment of women with glucoregulation abnormalitiesM Guido, D Romualdi, A Lanzone
Journal of Endocrinological Investigation|April 1, 2004
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: a case reportM Guido, D Romualdi, C Belosi, et al.
Journal of Endocrinological Investigation|October 10, 2013
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized studyD Romualdi, S De Cicco, M Busacca, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2011
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndromeD Romualdi, S De Cicco, V Tagliaferri, et al.
Human Reproduction (Oxford, England)|May 30, 2003
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndromeD Romualdi, M Guido, M Ciampelli, et al.
Human Reproduction (Oxford, England)|March 5, 2004
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndromeM Guido, D Romualdi, R Suriano, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot studyM Guido, D Romualdi, M Giuliani, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndromeM Ciampelli, G Muzj, F Leoni, et al.
Human Reproduction (Oxford, England)|October 21, 2006
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?C Belosi, L Selvaggi, R Apa, et al.
Journal of Endocrinological Investigation|March 9, 2019
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort studyD Romualdi, V Versace, V Tagliaferri, et al.
Pageof 2